Indian benchmark indices, the Sensex and Nifty, concluded Friday's trading session higher, setting the stage for a busy week of corporate news. The Sensex climbed 504.86 points (0.65%) to close at 78,493.54, while the Nifty gained 56.80 points (0.65%) to finish at 24,353.55. Several prominent companies are making headlines today due to their latest quarterly results, regulatory updates, and other strategic announcements.
Key Companies in Focus
ICICI Bank
ICICI Bank announced a standalone net profit of Rs 13,701.68 crore for the fourth quarter, an 8.5% year-on-year increase from Rs 12,629.58 crore in the same period last year. The board has also proposed a dividend of Rs 12 per share, pending shareholder approvals.
Trent
The Tata Group's retail arm, Trent, is poised to consider its inaugural bonus share issue during a board meeting scheduled for April 22. The company is also expected to release its financial results for the March 2026 quarter on the same day.
YES Bank
YES Bank reported a substantial 44.7% year-on-year surge in its standalone net profit for Q4, reaching Rs 1,068.42 crore, up from Rs 738.12 crore in the corresponding quarter of the previous fiscal year.
BHEL
Public sector undertaking BHEL disclosed a provisional turnover of Rs 32,350 crore for FY 2026, marking an 18% growth over the previous year. The company secured new orders worth Rs 75,000 crore during the year, elevating its total outstanding order book to Rs 2.4 lakh crore. Additionally, BHEL commissioned approximately 8.9 GW of power capacity.
HDFC Bank
HDFC Bank posted a 9.1% year-on-year increase in its standalone net profit for Q4, reaching Rs 19,221.05 crore, compared to Rs 17,616.14 crore in the prior year's period. The bank's board has recommended a final dividend of Rs 13 per equity share with a face value of Re 1 for the fiscal year ended March 31, 2026.
Cipla
Pharmaceutical major Cipla informed that the USFDA conducted a pre-approval inspection at its manufacturing facility in Goa from April 6 to April 17, 2026. The inspection concluded with the issuance of a Form 483, noting two observations.
Lupin
Another pharmaceutical company, Lupin, also faced a USFDA inspection at its Somerset facility between April 13 and April 17, 2026. The regulator issued three observations following the completion of the inspection.
Hyundai Motor India
Today marks the end of the one-and-a-half-year shareholder lock-in period for Hyundai Motor India. This development makes 162.5 million shares, representing 20% of its outstanding equity, eligible for trading. Based on Friday's closing price, these shares are valued at approximately Rs 30,700 crore.